Research & Development 2 min read China's Innovent says its GLP-1 works better than Novo's semaglutide in diabetes study The late-stage head-to-head trial compared different doses of the two drugs in patients with diabetes and obesity to assess glycemic control and weight loss
This dual action could offer complementary effects, supporting both appetite control and metabolic balance
It introduced several new weapons, new characters, both friendly and hostile (Otis Laurey the security guard and the Race X aliens, respectively) and new, previously unseen areas of the facility
This peptide-pathway test maps 14 metabolic pathways and 49 peptides to reveal whether your genetics support alternative GLP-1 compounds, microdose protocols, or dual-compound therapies
Set the GLP-1 weight-loss drugs aside, and BPC-157 is one of the loudest names in the peptide world
No Commitment - Pause or Cancel Anytime